'en:(aa).rpgr.0'
(id=6928788 ; fe=en:(aa).rpgr.0 ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=3968 creation date=2017-06-25 touchdate=2025-11-02 05:31:06.000) ≈ 107 relations sortantes
- en:(aa).rpgr.0 --
r_associated #0: 30 / 1 ->
en:ornithine-oxo-acid aminotransferase
n1=en:(aa).rpgr.0 | n2=en:ornithine-oxo-acid aminotransferase | rel=r_associated | relid=0 | w=30
- en:(aa).rpgr.0 --
r_associated #0: 29 / 0.967 ->
en:fanconi anemia group f protein
n1=en:(aa).rpgr.0 | n2=en:fanconi anemia group f protein | rel=r_associated | relid=0 | w=29
- en:(aa).rpgr.0 --
r_associated #0: 29 / 0.967 ->
en:transcription factor brn-3c
n1=en:(aa).rpgr.0 | n2=en:transcription factor brn-3c | rel=r_associated | relid=0 | w=29
- en:(aa).rpgr.0 --
r_associated #0: 28 / 0.933 ->
en:high-mobility group protein hmgi-c
n1=en:(aa).rpgr.0 | n2=en:high-mobility group protein hmgi-c | rel=r_associated | relid=0 | w=28
- en:(aa).rpgr.0 --
r_associated #0: 27 / 0.9 ->
en:b-lymphocyte antigen cd19
n1=en:(aa).rpgr.0 | n2=en:b-lymphocyte antigen cd19 | rel=r_associated | relid=0 | w=27
- en:(aa).rpgr.0 --
r_associated #0: 27 / 0.9 ->
en:keratin 6b protein
n1=en:(aa).rpgr.0 | n2=en:keratin 6b protein | rel=r_associated | relid=0 | w=27
- en:(aa).rpgr.0 --
r_associated #0: 27 / 0.9 ->
en:methylated-dna-protein-cysteine methyltransferase
n1=en:(aa).rpgr.0 | n2=en:methylated-dna-protein-cysteine methyltransferase | rel=r_associated | relid=0 | w=27
- en:(aa).rpgr.0 --
r_associated #0: 27 / 0.9 ->
en:proto-oncogene tyrosine-protein kinase src
n1=en:(aa).rpgr.0 | n2=en:proto-oncogene tyrosine-protein kinase src | rel=r_associated | relid=0 | w=27
- en:(aa).rpgr.0 --
r_associated #0: 26 / 0.867 ->
en:gamma-sarcoglycan
n1=en:(aa).rpgr.0 | n2=en:gamma-sarcoglycan | rel=r_associated | relid=0 | w=26
- en:(aa).rpgr.0 --
r_associated #0: 26 / 0.867 ->
en:keratin-4
n1=en:(aa).rpgr.0 | n2=en:keratin-4 | rel=r_associated | relid=0 | w=26
- en:(aa).rpgr.0 --
r_associated #0: 25 / 0.833 ->
en:fanconi anemia group c protein
n1=en:(aa).rpgr.0 | n2=en:fanconi anemia group c protein | rel=r_associated | relid=0 | w=25
- en:(aa).rpgr.0 --
r_associated #0: 25 / 0.833 ->
en:hla-drb4 antigen
n1=en:(aa).rpgr.0 | n2=en:hla-drb4 antigen | rel=r_associated | relid=0 | w=25
- en:(aa).rpgr.0 --
r_associated #0: 25 / 0.833 ->
en:malonyl-coa decarboxylase
n1=en:(aa).rpgr.0 | n2=en:malonyl-coa decarboxylase | rel=r_associated | relid=0 | w=25
- en:(aa).rpgr.0 --
r_associated #0: 25 / 0.833 ->
en:translation initiation factor eif-2b subunit epsilon
n1=en:(aa).rpgr.0 | n2=en:translation initiation factor eif-2b subunit epsilon | rel=r_associated | relid=0 | w=25
- en:(aa).rpgr.0 --
r_associated #0: 24 / 0.8 ->
en:keratin-2a
n1=en:(aa).rpgr.0 | n2=en:keratin-2a | rel=r_associated | relid=0 | w=24
- en:(aa).rpgr.0 --
r_associated #0: 24 / 0.8 ->
en:long-chain-acyl-coa dehydrogenase
n1=en:(aa).rpgr.0 | n2=en:long-chain-acyl-coa dehydrogenase | rel=r_associated | relid=0 | w=24
- en:(aa).rpgr.0 --
r_associated #0: 24 / 0.8 ->
en:pancreatic secretory trypsin inhibitor
n1=en:(aa).rpgr.0 | n2=en:pancreatic secretory trypsin inhibitor | rel=r_associated | relid=0 | w=24
- en:(aa).rpgr.0 --
r_associated #0: 23 / 0.767 ->
en:antigen ki-67
n1=en:(aa).rpgr.0 | n2=en:antigen ki-67 | rel=r_associated | relid=0 | w=23
- en:(aa).rpgr.0 --
r_associated #0: 22 / 0.733 ->
en:cyclic amp-dependent transcription factor atf-1
n1=en:(aa).rpgr.0 | n2=en:cyclic amp-dependent transcription factor atf-1 | rel=r_associated | relid=0 | w=22
- en:(aa).rpgr.0 --
r_associated #0: 22 / 0.733 ->
en:hla class ii histocompatibility antigen, dr alpha chain
n1=en:(aa).rpgr.0 | n2=en:hla class ii histocompatibility antigen, dr alpha chain | rel=r_associated | relid=0 | w=22
- en:(aa).rpgr.0 --
r_associated #0: 22 / 0.733 ->
en:keratin-9
n1=en:(aa).rpgr.0 | n2=en:keratin-9 | rel=r_associated | relid=0 | w=22
- en:(aa).rpgr.0 --
r_associated #0: 22 / 0.733 ->
en:keratin, type ii cytoskeletal 1
n1=en:(aa).rpgr.0 | n2=en:keratin, type ii cytoskeletal 1 | rel=r_associated | relid=0 | w=22
- en:(aa).rpgr.0 --
r_associated #0: 21 / 0.7 ->
en:b-cell lymphoma 6 protein
n1=en:(aa).rpgr.0 | n2=en:b-cell lymphoma 6 protein | rel=r_associated | relid=0 | w=21
- en:(aa).rpgr.0 --
r_associated #0: 21 / 0.7 ->
en:runt-related transcription factor 1
n1=en:(aa).rpgr.0 | n2=en:runt-related transcription factor 1 | rel=r_associated | relid=0 | w=21
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
élastase granulocytaire
n1=en:(aa).rpgr.0 | n2=élastase granulocytaire | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
émérine
n1=en:(aa).rpgr.0 | n2=émérine | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:(aa).mybpc3.0
n1=en:(aa).rpgr.0 | n2=en:(aa).mybpc3.0 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:25-hydroxyvitamin d-1 alpha-hydroxylase, mitochondrial
n1=en:(aa).rpgr.0 | n2=en:25-hydroxyvitamin d-1 alpha-hydroxylase, mitochondrial | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:26s proteasome complex subunit dss1
n1=en:(aa).rpgr.0 | n2=en:26s proteasome complex subunit dss1 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:3 beta-hydroxysteroid dehydrogenase type ii
n1=en:(aa).rpgr.0 | n2=en:3 beta-hydroxysteroid dehydrogenase type ii | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:a disintegrin and metalloproteinase with thrombospondin motifs 13
n1=en:(aa).rpgr.0 | n2=en:a disintegrin and metalloproteinase with thrombospondin motifs 13 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:apolipoprotein b-48
n1=en:(aa).rpgr.0 | n2=en:apolipoprotein b-48 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:ataxin-7
n1=en:(aa).rpgr.0 | n2=en:ataxin-7 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:b-cell antigen receptor complex-associated protein alpha chain
n1=en:(aa).rpgr.0 | n2=en:b-cell antigen receptor complex-associated protein alpha chain | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:baculoviral iap repeat-containing protein 5
n1=en:(aa).rpgr.0 | n2=en:baculoviral iap repeat-containing protein 5 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:breast cancer type 1 susceptibility protein
n1=en:(aa).rpgr.0 | n2=en:breast cancer type 1 susceptibility protein | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:breast cancer type 2 susceptibility protein
n1=en:(aa).rpgr.0 | n2=en:breast cancer type 2 susceptibility protein | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:breast cancer type 2 susceptibility protein, human
n1=en:(aa).rpgr.0 | n2=en:breast cancer type 2 susceptibility protein, human | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:cadherin-1
n1=en:(aa).rpgr.0 | n2=en:cadherin-1 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:campath-1 antigen
n1=en:(aa).rpgr.0 | n2=en:campath-1 antigen | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:cd27 antigen
n1=en:(aa).rpgr.0 | n2=en:cd27 antigen | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:cd40 ligand
n1=en:(aa).rpgr.0 | n2=en:cd40 ligand | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:cd79b gene
n1=en:(aa).rpgr.0 | n2=en:cd79b gene | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:collagen iv (alpha 3)
n1=en:(aa).rpgr.0 | n2=en:collagen iv (alpha 3) | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:complement factor h, human
n1=en:(aa).rpgr.0 | n2=en:complement factor h, human | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:cystathionine beta-synthase
n1=en:(aa).rpgr.0 | n2=en:cystathionine beta-synthase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:dna nucleotidylexotransferase
n1=en:(aa).rpgr.0 | n2=en:dna nucleotidylexotransferase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:early activation antigen cd69
n1=en:(aa).rpgr.0 | n2=en:early activation antigen cd69 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:electron-transferring-flavoprotein dehydrogenase
n1=en:(aa).rpgr.0 | n2=en:electron-transferring-flavoprotein dehydrogenase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:emerin
n1=en:(aa).rpgr.0 | n2=en:emerin | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:fanconi anemia group a protein
n1=en:(aa).rpgr.0 | n2=en:fanconi anemia group a protein | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:folliculin
n1=en:(aa).rpgr.0 | n2=en:folliculin | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:friend leukemia integration 1 transcription factor
n1=en:(aa).rpgr.0 | n2=en:friend leukemia integration 1 transcription factor | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:gigaxonin
n1=en:(aa).rpgr.0 | n2=en:gigaxonin | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:glycogen branching enzyme
n1=en:(aa).rpgr.0 | n2=en:glycogen branching enzyme | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:glycophorin-a
n1=en:(aa).rpgr.0 | n2=en:glycophorin-a | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:h/aca ribonucleoprotein complex subunit 4
n1=en:(aa).rpgr.0 | n2=en:h/aca ribonucleoprotein complex subunit 4 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:hereditary hemochromatosis protein
n1=en:(aa).rpgr.0 | n2=en:hereditary hemochromatosis protein | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:keratin, type ii cytoskeletal 5
n1=en:(aa).rpgr.0 | n2=en:keratin, type ii cytoskeletal 5 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:leukosialin, human
n1=en:(aa).rpgr.0 | n2=en:leukosialin, human | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:low affinity immunoglobulin epsilon fc receptor
n1=en:(aa).rpgr.0 | n2=en:low affinity immunoglobulin epsilon fc receptor | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:marenostrin
n1=en:(aa).rpgr.0 | n2=en:marenostrin | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:mast/stem cell growth factor receptor kit
n1=en:(aa).rpgr.0 | n2=en:mast/stem cell growth factor receptor kit | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:melanoma antigen recognized by t-cells 1, human
n1=en:(aa).rpgr.0 | n2=en:melanoma antigen recognized by t-cells 1, human | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:methylmalonyl-coa mutase
n1=en:(aa).rpgr.0 | n2=en:methylmalonyl-coa mutase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:myosin light chain 2
n1=en:(aa).rpgr.0 | n2=en:myosin light chain 2 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:neutrophil cytosolic factor 2
n1=en:(aa).rpgr.0 | n2=en:neutrophil cytosolic factor 2 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:neutrophil elastase
n1=en:(aa).rpgr.0 | n2=en:neutrophil elastase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:nucleophosmin
n1=en:(aa).rpgr.0 | n2=en:nucleophosmin | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:oculopharyngeal muscular dystrophy
n1=en:(aa).rpgr.0 | n2=en:oculopharyngeal muscular dystrophy | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:periaxin
n1=en:(aa).rpgr.0 | n2=en:periaxin | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:peripheral myelin protein 22, human
n1=en:(aa).rpgr.0 | n2=en:peripheral myelin protein 22, human | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:phakinin
n1=en:(aa).rpgr.0 | n2=en:phakinin | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:prions
n1=en:(aa).rpgr.0 | n2=en:prions | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:proactivator polypeptide
n1=en:(aa).rpgr.0 | n2=en:proactivator polypeptide | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:protein cbfa2t1
n1=en:(aa).rpgr.0 | n2=en:protein cbfa2t1 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:protein kinase c gamma type
n1=en:(aa).rpgr.0 | n2=en:protein kinase c gamma type | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:receptor-type tyrosine-protein kinase flt3
n1=en:(aa).rpgr.0 | n2=en:receptor-type tyrosine-protein kinase flt3 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:retinal phosphodiesterase, beta subunit
n1=en:(aa).rpgr.0 | n2=en:retinal phosphodiesterase, beta subunit | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:retinitis pigmentosa 3
n1=en:(aa).rpgr.0 | n2=en:retinitis pigmentosa 3 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:retinoschisin protein
n1=en:(aa).rpgr.0 | n2=en:retinoschisin protein | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:scavenger receptor cysteine-rich type 1 protein m130
n1=en:(aa).rpgr.0 | n2=en:scavenger receptor cysteine-rich type 1 protein m130 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:scavenger receptor cysteine-rich type 1 protein m130, human
n1=en:(aa).rpgr.0 | n2=en:scavenger receptor cysteine-rich type 1 protein m130, human | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:serine palmitoyltransferase 1, human
n1=en:(aa).rpgr.0 | n2=en:serine palmitoyltransferase 1, human | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:solute carrier-family-6 (neurotransmitter transporter, creatine), member 8
n1=en:(aa).rpgr.0 | n2=en:solute carrier-family-6 (neurotransmitter transporter, creatine), member 8 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:steroid 21-monooxygenase
n1=en:(aa).rpgr.0 | n2=en:steroid 21-monooxygenase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:steryl-sulfatase
n1=en:(aa).rpgr.0 | n2=en:steryl-sulfatase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:thrombopoietin receptor
n1=en:(aa).rpgr.0 | n2=en:thrombopoietin receptor | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:thymidylate synthase
n1=en:(aa).rpgr.0 | n2=en:thymidylate synthase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:transcription factor maf
n1=en:(aa).rpgr.0 | n2=en:transcription factor maf | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:transcription factor sox-2
n1=en:(aa).rpgr.0 | n2=en:transcription factor sox-2 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:transferrin receptor
n1=en:(aa).rpgr.0 | n2=en:transferrin receptor | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:trypsin-1
n1=en:(aa).rpgr.0 | n2=en:trypsin-1 | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:tuberin
n1=en:(aa).rpgr.0 | n2=en:tuberin | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:tumor necrosis factor receptor superfamily member 10c
n1=en:(aa).rpgr.0 | n2=en:tumor necrosis factor receptor superfamily member 10c | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:tyrosine-protein kinase zap-70, human
n1=en:(aa).rpgr.0 | n2=en:tyrosine-protein kinase zap-70, human | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:ubiquitin-protein ligase e3a
n1=en:(aa).rpgr.0 | n2=en:ubiquitin-protein ligase e3a | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
en:wilms tumor protein
n1=en:(aa).rpgr.0 | n2=en:wilms tumor protein | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
folliculine
n1=en:(aa).rpgr.0 | n2=folliculine | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
gigaxonine
n1=en:(aa).rpgr.0 | n2=gigaxonine | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
méthylmalonyl-CoA mutase
n1=en:(aa).rpgr.0 | n2=méthylmalonyl-CoA mutase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
méthylmalonyl-coa mutase
n1=en:(aa).rpgr.0 | n2=méthylmalonyl-coa mutase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
récepteur de la transferrine
n1=en:(aa).rpgr.0 | n2=récepteur de la transferrine | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
SKALP acr. pour skin derived antileukoproteinase
n1=en:(aa).rpgr.0 | n2=SKALP acr. pour skin derived antileukoproteinase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
thrombopoietin receptor
n1=en:(aa).rpgr.0 | n2=thrombopoietin receptor | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
thymidylate synthase
n1=en:(aa).rpgr.0 | n2=thymidylate synthase | rel=r_associated | relid=0 | w=20
- en:(aa).rpgr.0 --
r_associated #0: 20 / 0.667 ->
transferrine (récepteur de la)
n1=en:(aa).rpgr.0 | n2=transferrine (récepteur de la) | rel=r_associated | relid=0 | w=20
| ≈ 129 relations entrantes
- en:transferrin receptor ---
r_associated #0: 82 -->
en:(aa).rpgr.0
n1=en:transferrin receptor | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=82
- récepteur de la transferrine ---
r_associated #0: 78 -->
en:(aa).rpgr.0
n1=récepteur de la transferrine | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=78
- méthylmalonyl-CoA mutase ---
r_associated #0: 70 -->
en:(aa).rpgr.0
n1=méthylmalonyl-CoA mutase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=70
- en:methylmalonyl-coa mutase ---
r_associated #0: 69 -->
en:(aa).rpgr.0
n1=en:methylmalonyl-coa mutase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=69
- en:thrombopoietin receptor ---
r_associated #0: 63 -->
en:(aa).rpgr.0
n1=en:thrombopoietin receptor | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=63
- thrombopoietin receptor ---
r_associated #0: 60 -->
en:(aa).rpgr.0
n1=thrombopoietin receptor | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=60
- transferrine (récepteur de la) ---
r_associated #0: 49 -->
en:(aa).rpgr.0
n1=transferrine (récepteur de la) | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=49
- folliculine ---
r_associated #0: 46 -->
en:(aa).rpgr.0
n1=folliculine | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=46
- en:folliculin ---
r_associated #0: 45 -->
en:(aa).rpgr.0
n1=en:folliculin | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=45
- méthylmalonyl-coa mutase ---
r_associated #0: 45 -->
en:(aa).rpgr.0
n1=méthylmalonyl-coa mutase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=45
- en:collagen iv (alpha 3) ---
r_associated #0: 42 -->
en:(aa).rpgr.0
n1=en:collagen iv (alpha 3) | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=42
- gigaxonine ---
r_associated #0: 40 -->
en:(aa).rpgr.0
n1=gigaxonine | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=40
- élastase granulocytaire ---
r_associated #0: 40 -->
en:(aa).rpgr.0
n1=élastase granulocytaire | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=40
- en:keratin, type ii cytoskeletal 5 ---
r_associated #0: 39 -->
en:(aa).rpgr.0
n1=en:keratin, type ii cytoskeletal 5 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=39
- en:neutrophil elastase ---
r_associated #0: 39 -->
en:(aa).rpgr.0
n1=en:neutrophil elastase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=39
- en:26s proteasome complex subunit dss1 ---
r_associated #0: 37 -->
en:(aa).rpgr.0
n1=en:26s proteasome complex subunit dss1 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=37
- en:complement factor h, human ---
r_associated #0: 37 -->
en:(aa).rpgr.0
n1=en:complement factor h, human | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=37
- en:keratin-4 ---
r_associated #0: 37 -->
en:(aa).rpgr.0
n1=en:keratin-4 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=37
- en:tuberin ---
r_associated #0: 37 -->
en:(aa).rpgr.0
n1=en:tuberin | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=37
- en:fanconi anemia group a protein ---
r_associated #0: 36 -->
en:(aa).rpgr.0
n1=en:fanconi anemia group a protein | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=36
- en:gigaxonin ---
r_associated #0: 36 -->
en:(aa).rpgr.0
n1=en:gigaxonin | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=36
- en:breast cancer type 1 susceptibility protein ---
r_associated #0: 35 -->
en:(aa).rpgr.0
n1=en:breast cancer type 1 susceptibility protein | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=35
- en:cd40 ligand ---
r_associated #0: 35 -->
en:(aa).rpgr.0
n1=en:cd40 ligand | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=35
- en:keratin, type ii cytoskeletal 1 ---
r_associated #0: 35 -->
en:(aa).rpgr.0
n1=en:keratin, type ii cytoskeletal 1 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=35
- en:keratin-9 ---
r_associated #0: 35 -->
en:(aa).rpgr.0
n1=en:keratin-9 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=35
- en:methylated-dna-protein-cysteine methyltransferase ---
r_associated #0: 35 -->
en:(aa).rpgr.0
n1=en:methylated-dna-protein-cysteine methyltransferase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=35
- en:protein kinase c gamma type ---
r_associated #0: 35 -->
en:(aa).rpgr.0
n1=en:protein kinase c gamma type | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=35
- en:25-hydroxyvitamin d-1 alpha-hydroxylase, mitochondrial ---
r_associated #0: 34 -->
en:(aa).rpgr.0
n1=en:25-hydroxyvitamin d-1 alpha-hydroxylase, mitochondrial | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=34
- en:cd79b gene ---
r_associated #0: 34 -->
en:(aa).rpgr.0
n1=en:cd79b gene | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=34
- en:early activation antigen cd69 ---
r_associated #0: 34 -->
en:(aa).rpgr.0
n1=en:early activation antigen cd69 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=34
- en:electron-transferring-flavoprotein dehydrogenase ---
r_associated #0: 34 -->
en:(aa).rpgr.0
n1=en:electron-transferring-flavoprotein dehydrogenase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=34
- en:hereditary hemochromatosis protein ---
r_associated #0: 34 -->
en:(aa).rpgr.0
n1=en:hereditary hemochromatosis protein | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=34
- en:neutrophil cytosolic factor 2 ---
r_associated #0: 34 -->
en:(aa).rpgr.0
n1=en:neutrophil cytosolic factor 2 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=34
- en:steryl-sulfatase ---
r_associated #0: 34 -->
en:(aa).rpgr.0
n1=en:steryl-sulfatase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=34
- en:transcription factor maf ---
r_associated #0: 34 -->
en:(aa).rpgr.0
n1=en:transcription factor maf | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=34
- en:apolipoprotein b-48 ---
r_associated #0: 32 -->
en:(aa).rpgr.0
n1=en:apolipoprotein b-48 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=32
- en:breast cancer type 2 susceptibility protein ---
r_associated #0: 32 -->
en:(aa).rpgr.0
n1=en:breast cancer type 2 susceptibility protein | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=32
- en:leukosialin, human ---
r_associated #0: 32 -->
en:(aa).rpgr.0
n1=en:leukosialin, human | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=32
- en:melanoma antigen recognized by t-cells 1, human ---
r_associated #0: 32 -->
en:(aa).rpgr.0
n1=en:melanoma antigen recognized by t-cells 1, human | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=32
- en:phakinin ---
r_associated #0: 32 -->
en:(aa).rpgr.0
n1=en:phakinin | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=32
- en:transcription factor sox-2 ---
r_associated #0: 32 -->
en:(aa).rpgr.0
n1=en:transcription factor sox-2 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=32
- en:tumor necrosis factor receptor superfamily member 10c ---
r_associated #0: 32 -->
en:(aa).rpgr.0
n1=en:tumor necrosis factor receptor superfamily member 10c | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=32
- en:tyrosine-protein kinase zap-70, human ---
r_associated #0: 32 -->
en:(aa).rpgr.0
n1=en:tyrosine-protein kinase zap-70, human | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=32
- en:ubiquitin-protein ligase e3a ---
r_associated #0: 32 -->
en:(aa).rpgr.0
n1=en:ubiquitin-protein ligase e3a | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=32
- en:(aa).mybpc3.0 ---
r_associated #0: 31 -->
en:(aa).rpgr.0
n1=en:(aa).mybpc3.0 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=31
- en:breast cancer type 2 susceptibility protein, human ---
r_associated #0: 31 -->
en:(aa).rpgr.0
n1=en:breast cancer type 2 susceptibility protein, human | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=31
- en:myosin light chain 2 ---
r_associated #0: 31 -->
en:(aa).rpgr.0
n1=en:myosin light chain 2 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=31
- en:oculopharyngeal muscular dystrophy ---
r_associated #0: 31 -->
en:(aa).rpgr.0
n1=en:oculopharyngeal muscular dystrophy | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=31
- en:peripheral myelin protein 22, human ---
r_associated #0: 31 -->
en:(aa).rpgr.0
n1=en:peripheral myelin protein 22, human | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=31
- en:protein cbfa2t1 ---
r_associated #0: 31 -->
en:(aa).rpgr.0
n1=en:protein cbfa2t1 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=31
- en:solute carrier-family-6 (neurotransmitter transporter, creatine), member 8 ---
r_associated #0: 31 -->
en:(aa).rpgr.0
n1=en:solute carrier-family-6 (neurotransmitter transporter, creatine), member 8 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=31
- en:steroid 21-monooxygenase ---
r_associated #0: 31 -->
en:(aa).rpgr.0
n1=en:steroid 21-monooxygenase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=31
- en:b-cell antigen receptor complex-associated protein alpha chain ---
r_associated #0: 30 -->
en:(aa).rpgr.0
n1=en:b-cell antigen receptor complex-associated protein alpha chain | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=30
- en:emerin ---
r_associated #0: 30 -->
en:(aa).rpgr.0
n1=en:emerin | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=30
- en:fanconi anemia group f protein ---
r_associated #0: 30 -->
en:(aa).rpgr.0
n1=en:fanconi anemia group f protein | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=30
- en:friend leukemia integration 1 transcription factor ---
r_associated #0: 30 -->
en:(aa).rpgr.0
n1=en:friend leukemia integration 1 transcription factor | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=30
- en:glycogen branching enzyme ---
r_associated #0: 30 -->
en:(aa).rpgr.0
n1=en:glycogen branching enzyme | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=30
- en:h/aca ribonucleoprotein complex subunit 4 ---
r_associated #0: 30 -->
en:(aa).rpgr.0
n1=en:h/aca ribonucleoprotein complex subunit 4 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=30
- en:long-chain-acyl-coa dehydrogenase ---
r_associated #0: 30 -->
en:(aa).rpgr.0
n1=en:long-chain-acyl-coa dehydrogenase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=30
- en:translation initiation factor eif-2b subunit epsilon ---
r_associated #0: 30 -->
en:(aa).rpgr.0
n1=en:translation initiation factor eif-2b subunit epsilon | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=30
- émérine ---
r_associated #0: 30 -->
en:(aa).rpgr.0
n1=émérine | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=30
- en:3 beta-hydroxysteroid dehydrogenase type ii ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:3 beta-hydroxysteroid dehydrogenase type ii | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:b-lymphocyte antigen cd19 ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:b-lymphocyte antigen cd19 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:cyclic amp-dependent transcription factor atf-1 ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:cyclic amp-dependent transcription factor atf-1 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:gamma-sarcoglycan ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:gamma-sarcoglycan | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:hla class ii histocompatibility antigen, dr alpha chain ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:hla class ii histocompatibility antigen, dr alpha chain | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:hla-drb4 antigen ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:hla-drb4 antigen | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:keratin 6b protein ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:keratin 6b protein | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:low affinity immunoglobulin epsilon fc receptor ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:low affinity immunoglobulin epsilon fc receptor | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:marenostrin ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:marenostrin | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:mast/stem cell growth factor receptor kit ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:mast/stem cell growth factor receptor kit | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:nucleophosmin ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:nucleophosmin | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:pancreatic secretory trypsin inhibitor ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:pancreatic secretory trypsin inhibitor | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:proto-oncogene tyrosine-protein kinase src ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:proto-oncogene tyrosine-protein kinase src | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:retinal phosphodiesterase, beta subunit ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:retinal phosphodiesterase, beta subunit | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:scavenger receptor cysteine-rich type 1 protein m130 ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:scavenger receptor cysteine-rich type 1 protein m130 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:thymidylate synthase ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:thymidylate synthase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- en:transcription factor brn-3c ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=en:transcription factor brn-3c | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- thymidylate synthase ---
r_associated #0: 29 -->
en:(aa).rpgr.0
n1=thymidylate synthase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=29
- SKALP acr. pour skin derived antileukoproteinase ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=SKALP acr. pour skin derived antileukoproteinase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:a disintegrin and metalloproteinase with thrombospondin motifs 13 ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:a disintegrin and metalloproteinase with thrombospondin motifs 13 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:antigen ki-67 ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:antigen ki-67 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:ataxin-7 ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:ataxin-7 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:b-cell lymphoma 6 protein ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:b-cell lymphoma 6 protein | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:cd27 antigen ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:cd27 antigen | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:fanconi anemia group c protein ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:fanconi anemia group c protein | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:glycophorin-a ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:glycophorin-a | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:high-mobility group protein hmgi-c ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:high-mobility group protein hmgi-c | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:keratin-2a ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:keratin-2a | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:periaxin ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:periaxin | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:scavenger receptor cysteine-rich type 1 protein m130, human ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:scavenger receptor cysteine-rich type 1 protein m130, human | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:wilms tumor protein ---
r_associated #0: 28 -->
en:(aa).rpgr.0
n1=en:wilms tumor protein | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=28
- en:dna nucleotidylexotransferase ---
r_associated #0: 27 -->
en:(aa).rpgr.0
n1=en:dna nucleotidylexotransferase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=27
- en:ornithine-oxo-acid aminotransferase ---
r_associated #0: 27 -->
en:(aa).rpgr.0
n1=en:ornithine-oxo-acid aminotransferase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=27
- en:prions ---
r_associated #0: 27 -->
en:(aa).rpgr.0
n1=en:prions | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=27
- en:proactivator polypeptide ---
r_associated #0: 27 -->
en:(aa).rpgr.0
n1=en:proactivator polypeptide | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=27
- en:retinitis pigmentosa 3 ---
r_associated #0: 27 -->
en:(aa).rpgr.0
n1=en:retinitis pigmentosa 3 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=27
- en:runt-related transcription factor 1 ---
r_associated #0: 27 -->
en:(aa).rpgr.0
n1=en:runt-related transcription factor 1 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=27
- en:serine palmitoyltransferase 1, human ---
r_associated #0: 27 -->
en:(aa).rpgr.0
n1=en:serine palmitoyltransferase 1, human | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=27
- en:baculoviral iap repeat-containing protein 5 ---
r_associated #0: 26 -->
en:(aa).rpgr.0
n1=en:baculoviral iap repeat-containing protein 5 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=26
- en:cadherin-1 ---
r_associated #0: 26 -->
en:(aa).rpgr.0
n1=en:cadherin-1 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=26
- en:campath-1 antigen ---
r_associated #0: 26 -->
en:(aa).rpgr.0
n1=en:campath-1 antigen | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=26
- en:cystathionine beta-synthase ---
r_associated #0: 26 -->
en:(aa).rpgr.0
n1=en:cystathionine beta-synthase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=26
- en:malonyl-coa decarboxylase ---
r_associated #0: 26 -->
en:(aa).rpgr.0
n1=en:malonyl-coa decarboxylase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=26
- en:receptor-type tyrosine-protein kinase flt3 ---
r_associated #0: 26 -->
en:(aa).rpgr.0
n1=en:receptor-type tyrosine-protein kinase flt3 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=26
- en:retinoschisin protein ---
r_associated #0: 26 -->
en:(aa).rpgr.0
n1=en:retinoschisin protein | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=26
- en:trypsin-1 ---
r_associated #0: 26 -->
en:(aa).rpgr.0
n1=en:trypsin-1 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=26
- cystathionine bêta-synthase ---
r_associated #0: 25 -->
en:(aa).rpgr.0
n1=cystathionine bêta-synthase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=25
- en:beta 2-glycoprotein i ---
r_associated #0: 25 -->
en:(aa).rpgr.0
n1=en:beta 2-glycoprotein i | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=25
- en:beta-globins ---
r_associated #0: 25 -->
en:(aa).rpgr.0
n1=en:beta-globins | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=25
- en:beta-mannosidase ---
r_associated #0: 25 -->
en:(aa).rpgr.0
n1=en:beta-mannosidase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=25
- en:carbonic anhydrase ii ---
r_associated #0: 25 -->
en:(aa).rpgr.0
n1=en:carbonic anhydrase ii | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=25
- en:hemoglobin subunit alpha ---
r_associated #0: 25 -->
en:(aa).rpgr.0
n1=en:hemoglobin subunit alpha | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=25
- en:hemoglobin subunit zeta ---
r_associated #0: 25 -->
en:(aa).rpgr.0
n1=en:hemoglobin subunit zeta | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=25
- en:hydroxymethylbilane synthase ---
r_associated #0: 25 -->
en:(aa).rpgr.0
n1=en:hydroxymethylbilane synthase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=25
- en:phenylalanine hydroxylase ---
r_associated #0: 25 -->
en:(aa).rpgr.0
n1=en:phenylalanine hydroxylase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=25
- en:receptor 4, trail ---
r_associated #0: 25 -->
en:(aa).rpgr.0
n1=en:receptor 4, trail | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=25
- en:stromelysin-3 ---
r_associated #0: 25 -->
en:(aa).rpgr.0
n1=en:stromelysin-3 | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=25
- Thymidylate synthase ---
r_associated #0: 10 -->
en:(aa).rpgr.0
n1=Thymidylate synthase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=10
- éjection ventriculaire (temps d') ---
r_associated #0: 10 -->
en:(aa).rpgr.0
n1=éjection ventriculaire (temps d') | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=10
- élafine ---
r_associated #0: 10 -->
en:(aa).rpgr.0
n1=élafine | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=10
- élargissement des lamelles myéliniques ---
r_associated #0: 10 -->
en:(aa).rpgr.0
n1=élargissement des lamelles myéliniques | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=10
- élastance ---
r_associated #0: 10 -->
en:(aa).rpgr.0
n1=élastance | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=10
- élastance pulmonaire ---
r_associated #0: 10 -->
en:(aa).rpgr.0
n1=élastance pulmonaire | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=10
- élastance vasculaire ---
r_associated #0: 10 -->
en:(aa).rpgr.0
n1=élastance vasculaire | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=10
- élastase ---
r_associated #0: 10 -->
en:(aa).rpgr.0
n1=élastase | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=10
- Membre 10c de la superfamille des récepteurs du facteur de nécrose tumorale ---
r_associated #0: 5 -->
en:(aa).rpgr.0
n1=Membre 10c de la superfamille des récepteurs du facteur de nécrose tumorale | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=5
- antigène CD19 des lymphocytes B ---
r_associated #0: 5 -->
en:(aa).rpgr.0
n1=antigène CD19 des lymphocytes B | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=5
- protéine de la tumeur de Wilms ---
r_associated #0: 5 -->
en:(aa).rpgr.0
n1=protéine de la tumeur de Wilms | n2=en:(aa).rpgr.0 | rel=r_associated | relid=0 | w=5
|